Skip to content
Search

Latest Stories

CCA identifies four key pointers for delivering NHS pharmacy plans

Since the introduction of the 2019 NHS Long-Term Plan, several policy commitments have surfaced, presenting a definitive 'blueprint' for community pharmacy in England. The Company Chemists Association has identified four crucial commitments that, when integrated, hold the potential to revolutionise patient care through community pharmacies.

“Each commitment is like a crucial piece of a puzzle,” CCA said. “For the transformation of patient access through community pharmacy to be successful, all these pieces must come together harmoniously. Otherwise, the picture will remain incomplete.”


The four major pieces of the puzzle coined by CCA include:

• Building on education and training reforms to increase the size and capability of the workforce.

• Expanding the number of clinical services commissioned and delivered in community pharmacy.

• Introducing digital enablers which underpin service delivery.

• Introducing legislative changes to increase capacity and allow the delivery of more patient-facing clinical care.

“The challenges in the sector are significant,” said Malcolm Harrison, Chief Executive of the CCA. “Historic underfunding, a continued workforce crisis and continued delays in the rollout of promised efficiencies have created a perfect storm. We still need action for the ‘here and now’, otherwise the pharmacy network will continue to deteriorate.”

According to CCA, the success of any commitments depends on implementation through cooperation between policymakers and the sector. “The recent announcements in the Primary Care Recovery Plan and the NHS Workforce Plan are positive, but the focus must now shift to actual implementation.”

Furthermore, careful planning and partnership are essential to fully grasp opportunities like Independent Prescribing, CCA added.

CCA said clear goals and milestones are essential for measuring the impact of changes on patients and helping pharmacy businesses evaluate costs and benefits for further investment. “Timely and effective implementation is crucial to address the urgent needs of patients and the NHS.”

Meanwhile, the Expert Panel's report on the community pharmacy sector's funding, published on Tuesday (25 July), highlights the need for improvement. The review of nine Government commitments, including seven from the Community Pharmacy Contractual Framework, indicates inadequate funding to sustain pharmacies amidst rising demands, workforce pressures, and inflation-related costs.

More For You

ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Independent Prescribing: Government aims to complete pathfinder programme evaluation by autumn 2025

Pharmacist prescribers at 210 ‘pathfinder’ sites were allowed to trial prescribing models within integrated primary care services.

Photo credit: gettyimages

Independent prescribing: Pathfinder programme evaluation to be completed by autumn, says Kinnock

Health minister Stephen Kinnock has revealed that the evaluation of the Community Pharmacy Independent Prescribing Pathfinder Programme could be completed by Autumn 2025.

Kinnock was responding to a question from James Naish, Labour MP for Rushcliffe, who asked what steps the minister was taking to ensure continued support for the Pathfinder Programme and independent prescribing to maximise direct prescribing capacity in England.

Keep ReadingShow less
NHS pharmacy funding not enough 2025: £3.073B deal with £1.99B gap fuels reform debate.

Funding alone isn’t going to be enough to save community pharmacy

Photo credit: gettyimages

New funding contract ‘not enough’ to release the sector from financial blackhole

After almost a year without an agreement, a new funding contract for community pharmacy was finally announced yesterday (31 March).

The settlement raises the baseline annual funding for the Community Pharmacy Contractual Framework (CPCF) in 2025/26 to £3.073 billion, with an additional £215 million secured to continue Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less